Fler resultat...
Pancreatic Cancer Europe recently interviewed Christina Gerde, patient representative and member of the Pancreatic Cancer Diagnosis Working Group at PALEMA. In her powerful message, Christina reminds us. More needs to be done for pancreatic cancer for survival rates to go up. The time for that is now.
Välkommen att kontakta PALEMAs redaktion om du har förslag på artiklar eller synpunkter på artiklar vi skrivit.
Dela – Mejla – Skriv ut:
Results from a major international study are raising hopes for one of the biggest breakthroughs in pancreatic cancer in decades.
For many people with pancreatic cancer, surgery is not an option at the time of diagnosis. But that doesn’t mean treatment stops—it means the treatment strategy changes.
Christina Gerde speaks on behalf of those who cannot speak for themselves, those living with pancreatic cancer, and those who have lost loved ones to the disease. She was diagnosed three years ago and shares the reality of a disease where relapse is common and treatment options remain limited.
Biotech company Alligator Bioscience AB interviews PALEMA in its annual report for 2025 and discusses, among other things, Emergency cancer (Blåljuscancer), medical needs, clinical studies and what message PALEMA wants to send to decision-makers and healthcare.